Australia

World Orphan Drug Alliance Welcomes Specialised Therapeutics

* SEA's largest independent specialty pharma company Specialised Therapeutics (ST) has joined global pharma consortium committed to collaborating to provide new specialist medicines for rare diseases. * ST to represent WODA in Australia, New Zealand and across Southeast Asia (ANZSEA). * Wor...

2023-09-08 04:00 1776

Discover the Legumes From Europe project. Which legumes have the highest amounts of protein and why you should make them part of your diet.

SYDNEY, Sept. 5, 2023 /PRNewswire/ -- Encouraging the consumption of legumes is one of the objectives of theLegumes from Europe campaign led by ANICAV – the National Association of Canned Vegetable Industries – and co-funded by the European Union to promote a healthier and more active lifestyle, ...

2023-09-05 15:00 1607

ACM Biolabs Announces Positive Topline Results from a Phase I Trial of SARS-CoV-2 Booster Vaccine ACM-001

*  Provides clinical validation for ACM Biolab's Tunable Platform ("ATP™"), ACM Biolab's proprietary polymer-based delivery platform *  ACM-001 was well tolerated at the recommended dose levels with no serious adverse events and encouraging early immunogenicity data *  ACM is in partnering d...

2023-09-05 14:00 1612

First participant treated at the highest dose level in Clarity's theranostic prostate cancer trial

Highlights * First participant of cohort 3 in the theranostic SECuRE trial investigating 64Cu/67Cu SAR-bisPSMA in metastatic castrate-resistant prostate cancer (mCRPC) has been treated at the highest dose level of 12GBq. * Cohort 2 was recently completed in 3 participants who received therapy...

2023-08-25 20:58 2769

Noodoe Links Californian and Australian Efforts to Combat Global Climate Change

With its newly opened Brisbane offices, Noodoe enables businesses from California to Australia to drive the adoption of sustainable transportation. IRVINE, Calif., Aug. 17, 2023 /PRNewswire/ -- Noodoe today announced the opening of its new offices inBrisbane, Australia as the next step in its wor...

2023-08-18 03:47 2149

THE CONQUEROR TEAMS UP WITH WARNER BROS. DISCOVERY GLOBAL CONSUMER PRODUCTS TO LAUNCH THE ULTIMATE SERIES OF VIRTUAL FITNESS CHALLENGES INSPIRED BY HBO'S GAME OF THRONES

Five Challenges, Five Medals, Following the Extraordinary Journeys of Jon Snow, Tyrion Lannister,Arya Stark, Daenerys Targaryen, and more. TAURANGA, New Zealand, Aug. 16, 2023 /PRNewswire/ -- The Conqueror Virtual Challenges, in collaboration with Warner Bros. Discovery Global Consumer Products,...

2023-08-16 14:00 1745

Inmagene's OX40 mAb, with an extended half-life and silenced ADCC, enters POC study in Atopic Dermatitis

SAN DIEGO, SHANGHAI and SYDNEY, Aug. 15, 2023 /PRNewswire/ -- Inmagene Biopharmaceuticals ("Inmagene"), a clinical stage biotechnology company developing innovative and differentiated therapies for immunological and inflammatory diseases, announced that the first patient has been dosed in a glob...

2023-08-15 22:50 2394

HB11 Energy receives grant from US Department of Energy to develop clean, safe and unlimited fusion energy

SYDNEY, Aug. 15, 2023 /PRNewswire/ -- The U.S. Department of Energy (DoE) has awarded a grant toHB11 Energy as part of its 'Innovation Network for Fusion Energy' (INFUSE ) program with the objective, "to accelerate basic research to develop cost-ef...

2023-08-15 21:00 1756

Clarity's theranostic prostate cancer trial advances to highest dose level

Highlights * Cohort 2 of the theranostic SECuRE trial investigating 64Cu/67Cu SAR-bisPSMA in metastatic castrate-resistant prostate cancer (mCRPC) has been completed in 3 participants who received therapy with67Cu SAR-bisPSMA at the dose level of 8GBq. * No dose limiting toxicities (DLTs) ha...

2023-08-10 20:58 2430

AI-based wastewater sampling predicts COVID pressure on hospitals

SYDNEY, Aug. 7, 2023 /PRNewswire/ -- New research shows it is possible to accurately predict hospital admission numbers due to COVID-19 up to four weeks in advance with an Artificial Intelligence (AI) based system using COVID wastewater sampling.

2023-08-07 21:13 1692

Relume Launches World's First AI-Powered Site Builder that exports to Webflow and Figma

SYDNEY, Aug. 7, 2023 /PRNewswire/ -- Sydney-based startup Relume has launched the world's first AI-powered site builder that exports to Webflow and Figma. The new site builder allows users to easily create website wireframes with just a prompt and export them to Figma and Webflow, saving time and...

2023-08-07 15:00 1319

Arbele announces early safety data for novel CDH17xCD3 bispecific T-cell engager at American Society of Clinical Oncology Breakthrough Meeting

SYDNEY, Aug. 2, 2023 /PRNewswire/ -- Arbele, a clinical-stage biotechnology company developing novel immunotherapies targeted for advanced gastrointestinal cancers, presented early safety data from its first-in-class CDH17xCD3 bispecific T-cell engager antibody, ARB202, at the ASCO Breakthrough c...

2023-08-03 07:00 1331

GLOBAL SARCOMA THERAPY NOW LISTED ON PHARMACEUTICAL BENEFITS SCHEME

* YONDELIS® (trabectedin) now PBS listed for Australian patients * Listing described as "wonderful news" for patients living with rare lipo and leiomyo sarcomas * YONDELISÒ (trabectedin) demonstrates 45% reduction in risk of disease progression or death versus dacarbazine1 SINGAPORE, July 31...

2023-07-31 15:00 1704

Gem Rock Auctions Celebrates Remarkable Milestone of Selling 1 Million Exquisite Gemstones Online

GOLD COAST, Australia, July 30, 2023 /PRNewswire/ -- Gem Rock Auctions, the leading online marketplace for gemstones, celebrates a remarkable milestone as its 320 sellers worldwide have collectively sold over 1 million gemstones to 179 countries. With an impressive inventory of over 1,000 gemston...

2023-07-31 07:00 1575

HaemaLogiX and Peter MacCallum Cancer Centre Announce Myeloma CAR-T Phase I Clinical Trial Agreement

* HaemaLogiX and Peter MacCallum Cancer Centre have entered a collaboration agreement to develop and conduct the first Phase I human trial of HaemaLogiX's CAR-T cell therapy in patients with kappa-type myeloma * The agreement is the culmination of previous preclinical research collaboration b...

2023-07-25 19:30 1342

Clarity reaches 50% recruitment milestone for Phase II SABRE prostate cancer trial

SYDNEY, July 24, 2023 /PRNewswire/ -- Clarity Pharmaceuticals (ASX: CU6) ("Clarity", "the Company"), a clinical stage radiopharmaceutical company with a mission to develop next-generation products that improve treatment outcomes for children and adults with cancer, is pleased to announce the Phas...

2023-07-24 21:02 1868

New 6clicks Trust Portal Features Combine Transparency and Security for Sharing Compliance and Privacy Information with Customers and Partners

Trust Management System Puts an End to "One Size Fits All" Privacy and Compliance Statements and Enables Granular Control of Disclosure MELBOURNE, Australia, July 12, 2023 /PRNewswire/ -- 6clicks , the leading AI-powered GRC platform for businesses and advisors, today a...

2023-07-13 06:31 2059

ForwardX Robotics Announces Exclusive Distribution Partnership with Richmond Rolling Solutions

Expanding the Future of Intelligent Automation in Australia and New Zealand BEIJING, July 12, 2023 /PRNewswire/ -- ForwardX Robotics, a global leader in vision-based AMR technology, is thrilled to announce its exclusive distribution partnership with Richmond Rolling Solutions, a renowned provider...

2023-07-12 19:56 2156

Race executes agreement with Ardena for GMP manufacturing of RC220

* Race Oncology executes agreement with leading global contract development and manufacturing organisation, Ardena as additional partner for GMP manufacturing of flagship RC220 bistanrene formulation * Ardena has a long track record of providing sterile injectable products for all stages of c...

2023-07-12 19:30 2355

CULTURE TRIP - MILLENNIAL FOCUSED TOUR OPERATOR COMPLETES MBO AND LAUNCHES STRATEGIC REVIEW

LONDON, July 11, 2023 /PRNewswire/ -- Culture Trip , the purpose-led small-group tour operator, today announces that the Company has completed a management buyout ("MBO"), led by CEOAna Jakimovska, and has launched a strategic review to ensure that the business contin...

2023-07-12 07:04 2192
1 ... 6789101112 ... 54

Week's Top Stories